SCHEMBL6202048

SCHEMBL6202048

Nc1ccc2c(c1)CC(N)C2

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.52
CA2 P00918 3/20 0.52
CA12 O43570 2/20 0.52
CA7 P43166 2/20 0.52
CA14 Q9ULX7 2/20 0.52
FYN P06241 1/20 0.50
DRD2 P14416 2/20 0.42
DRD3 P35462 2/20 0.42
OPRK1 P41145 1/20 0.42
MAPT P10636 3/20 0.42
ALDH1A1 P00352 2/20 0.42
KDM4E B2RXH2 2/20 0.42
NPC1 O15118 1/20 0.42
LMNA P02545 1/20 0.42
HPGD P15428 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
PSEN1 P49768 1/20 0.41
PSEN2 P49810 1/20 0.41
APH1B Q8WW43 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4065731 1.00 CA1 (0.52) CA1CA2CA12CA7CA14
Hydrochloric Acid SCHEMBL7760859 0.98 CA1 (0.53) CA1CA2CA12CA7CA14
Hydrochloric Acid SCHEMBL10401256 0.98 CA1 (0.53) CA1CA2CA12CA7CA14
SCHEMBL9752112 0.83 DRD2 (0.65) DRD2DRD3OPRK1MAPTALDH1A1
SCHEMBL30324474 0.83 DRD2 (0.65) DRD2DRD3OPRK1MAPTALDH1A1
SCHEMBL9776865 0.83 OPRK1 (0.65) DRD2DRD3OPRK1MAPTALDH1A1
Hydrochloric Acid SCHEMBL29816599 0.81 DRD2 (0.62) DRD2DRD3OPRK1MAPTALDH1A1
SCHEMBL2061751 0.80 OPRK1 (0.51) DRD2DRD3OPRK1MAPTALDH1A1
SCHEMBL4232589 0.79 MAPT (0.41) CA1CA2CA12CA7CA14
SCHEMBL3709225 0.79 LMNA (0.41) CA1CA2CA12CA7CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6197798-B1 INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN NOVARTIS AG (CH) 2001-03-06 US claimed
WO-2014145512-A2 POTENT SMALL MOLECULE INHIBITORS OF AUTOPHAGY, AND METHODS OF USE THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2014-09-18 WO disclosed
WO-2014145512-A2 POTENT SMALL MOLECULE INHIBITORS OF AUTOPHAGY, AND METHODS OF USE THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2014-09-18 WO disclosed
EP-2049532-B1 CGRP RECEPTOR ANTAGONISTS VERTEX PHARMA (US) 2010-06-02 EP disclosed
WO-2008021849-A2 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS SMITHKLINE BEECHAM CORPORATION (US) 2008-02-21 WO disclosed
WO-2007047397-A2 PHENOL ETHERS AS MODULATORS OF THE OPIOID RECEPTORS SMITHKLINE BEECHAM CORPORATION (US) 2007-04-26 WO disclosed
US-6949575-B2 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoindane derivatives PFIZER INC. (US) 2005-09-27 US disclosed
EP-1284958-B1 METHOD OF INHIBITING AMYLOID PROTEIN AGGREGATION AND IMAGING AMYLOID DEPOSITS USING AMINOIDANE DERIVATIVES WARNER LAMBERT CO (US) 2005-09-14 EP disclosed
EP-1259484-B1 CARBOXAMIDES USEFUL AS INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND OF APOLIPOPROTEIN B SECRETION NOVARTIS AG (CH) 2005-05-18 EP disclosed
US-6878707-B2 Carboxamides useful as inhibitors of microsomal triglyceride transfer protein and of apolipoprotein b secretion NOVARTIS AG (CH) 2005-04-12 US disclosed
EP-1284958-A1 METHOD OF INHIBITING AMYLOID PROTEIN AGGREGATION AND IMAGING AMYLOID DEPOSITS USING AMINOIDANE DERIVATIVES WARNER-LAMBERT COMPANY (US) 2003-02-26 EP disclosed
EP-1259484-A1 CARBOXAMIDES USEFUL AS INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND OF APOLIPOPROTEIN B SECRETION Novartis AG (CH) 2002-11-27 EP disclosed
WO-2001083425-A1 METHOD OF INHIBITING AMYLOID PROTEIN AGGREGATION AND IMAGING AMYLOID DEPOSITS USING AMINOINDANE DERIVATIVES WARNER-LAMBERT COMPANY (US) 2001-11-08 WO disclosed
WO-2001053260-A1 CARBOXAMIDES USEFUL AS INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND OF APOLIPOPROTEIN B SECRETION NOVARTIS AG (CH) 2001-07-26 WO disclosed
EP-1097129-A1 N-BENZOCYCLOALKYL-AMIDE DERIVATIVES AND THEIR USE AS MEDICAMENTS Novartis AG (CH) 2001-05-09 EP disclosed
US-6197798-B1 INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN NOVARTIS AG (CH) 2001-03-06 US disclosed
WO-2001005767-A1 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2001-01-25 WO disclosed
WO-2000005201-A1 N-BENZOCYCLOALKYL-AMIDE DERIVATIVES AND THEIR USE AS MEDICAMENTS NOVARTIS AG (CH) 2000-02-03 WO disclosed
US-4963587-A ANTICOAGULANT TANABE SEIYAKU CO., LTD. (JP) 1990-10-16 US disclosed
EP-0377977-A1 Glycine derivatives and preparation thereof TANABE SEIYAKU CO., LTD. (JP) 1990-07-18 EP disclosed